HAIXI PHARMA 02637Hong Kong Stock Exchange

155.5000.32%( +0.500 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HAIXI PHARMA (02637) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Fujian Haixi Pharmaceuticals Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-10-20
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007515
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)682.91M64/112
Net Profit (Last FY)207.60M42/125
ROE (Last FY)11.11%26/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
康心汕 Executive Director
Feng Yan Executive Director
Chen Guangming Executive Director
李俊青 Executive Director
陈廷泽 Executive Director
许冬 Non-Executive Director
林斌 Independent Non-Executive Director
王珊珊 Independent Non-Executive Director
蒲美婷 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-04.

About this page

This page shows HAIXI PHARMA (02637) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.